Directly Compressible Granules

Directly Compressible Granules
Product Description

1. Aceclofenac Granules 50%2. Clopidogrel Granules 60% 3. Fexofenadine Granules 48% 4. Gliclazide Granules SR 48% 5. Levitiracetam Granules SR 75%, 80% 6. Lisinopril Granules 50% 7. Metformin HCL Granules IR 86.66%, 93% 8. Metformin HCL Granules SR 75%, 80% 9. Montelukast Granules 7.1% 10. Paracetamol Granules 83%, 90%, 96% 11. Sildenafil Citrate Granules 25% 12. Sitagliptin Granules 25.3% 13. Tadalafil Granules 20% 14. Telmisartan Granules 20% 15. Valproic acid Granules SR 66.7% 16. Vildagliptin Granules 25.3%

YSK Laboratories Pvt Ltd

  • IN
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Specifications

YSK Laboratories Pvt Ltd

  • IN
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from YSK Laboratories Pvt Ltd (3)

YSK Laboratories Pvt Ltd resources (2)

  • News YSK Labs - CCD partners Watchlist 2023

    YSK Labs was featured on the CCD partners Watchlist 2023 aimed to highlight the profile of Innovative and disruptive Startup companies participating in the CPHI Startup Market 2023. This Watchlist is designed to capture and track exciting up-and-coming businesses with the potential to disrupt the pharmaceutical industry. 

    Out of approximately 1000+ companies in over 57 countries, YSK Labs was amongst the 21 companies selected and featured.